Ginkgo Bioworks Holdings Inc. logo

Ginkgo Bioworks Holdings Inc. (DNA)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
10. 28
-1.48
-12.585%
$
849.22M Market Cap
- P/E Ratio
- Div Yield
173,516 Volume
-0.32 Eps
$ 11.76
Previous Close
Analysts:
Add Transaction
Day Range
10.12 11.72
Year Range
5.37 18.22
Want to track DNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

The latest trading day saw Ginkgo Bioworks Holdings, Inc. (DNA) settling at $9, representing a -3.12% change from its previous close.

Zacks | 8 months ago
Amazon's DNA: Why Hoarding Cash Is Secondary To Building Empires

Amazon's DNA: Why Hoarding Cash Is Secondary To Building Empires

Amazon delivered robust Q4 2025 results, with accelerating revenue growth and AWS leading at 23.6% YoY. AMZN's operating margin reached a historic high of 11.8%, driven by strong AWS profitability at a 35% margin. The stock sold off after management guided FY 2026 CapEx to $200bn, 50% above FY 2025 and exceeding operating cash flow by $60bn.

Seekingalpha | 8 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know

Ginkgo Bioworks Holdings, Inc. (DNA) reached $9.23 at the closing of the latest trading day, reflecting a -9.06% change compared to its last close.

Zacks | 8 months ago
Allegiant Travel: Cost Discipline DNA Returns, Sun Country Airlines' Upside

Allegiant Travel: Cost Discipline DNA Returns, Sun Country Airlines' Upside

Allegiant Travel Company demonstrates disciplined capacity management and cost control, supporting a "Buy" rating and strong post-earnings stock performance. Q4 2025 results show a swing to profitability with a 10.2% operating margin, despite modest margin compression and reduced unit revenues. ALGT targets stable capacity and efficiency gains in 2026, leveraging Boeing 737 MAX upgrades to drive cost improvements without diluting unit revenues.

Seekingalpha | 8 months ago
Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today

Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today

In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $8.27, denoting a -5.92% move from the preceding trading day.

Zacks | 8 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors

Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $9.31, signifying a -1.27% move from its prior day's close.

Zacks | 8 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02, marking a -6.36% move from the previous day.

Zacks | 8 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know

Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know

In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.85, indicating a +2.39% shift from the previous trading day.

Zacks | 9 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.06, marking a -5.72% move from the previous day.

Zacks | 9 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $8.31, indicating a +1.96% shift from the previous trading day.

Zacks | 9 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2025 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. ( DNA ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Daniel Waid Marshall Jason Kelly - Founder, CEO & Director Steven Coen - Chief Accounting Officer & CFO Presentation Daniel Waid Marshall [Audio Gap] Manager of Communications and Ownership at Ginkgo. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Coen, our CFO.

Seekingalpha | 11 months ago
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.

Zacks | 11 months ago
Loading...
Load More